The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
According to the Autism Society of America 1 in 54 children are diagnosed with autism, ten years ago it was 1 in 125. There are now over 3.5 million individuals on the autism spectrum in the US alone.1
To varying degrees, depending on the severity of a person’s autism and their age, there are several challenging behaviours that autistic people can exhibit such as:
Dr Sarah McAllister - 18th July 2018 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Dr Sarah McAllister shares her Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.
Dickson Chemist developed a new formulation of LDN which will hopefully improve the outcomes for patients. This new formulation is a more concentrated liquid in the form of drops which are administered under the tongue and absorbed directly from the mucosal lining of the mouth. This sublingual route produces a more rapid absorption bypassing the liver and digestive tract. There are several potential advantages to this, the drug may be more effective and will not be affected by the presence of food stuffs or the hostile environment of the gut.